Successful treatment of intractable chronic spontaneous urticaria with omalizumab in a patient with ovarian cancer

Eur J Dermatol. 2021 Feb 1;31(1):100-101. doi: 10.1684/ejd.2020.3959.

Authors

Koremasa Hayama¹, Hideki Fujita¹, Mikiko Asai-Sato², Kei Kawana², Tadashi Terui¹

Affiliations

¹ Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan.
² Department of Obstetrics and Gynaecology, Nihon University School of Medicine, Tokyo, Japan.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anti-Allergic Agents / therapeutic use*
Chronic Urticaria / drug therapy*
Chronic Urticaria / etiology
Female
Humans
Middle Aged
Omalizumab / therapeutic use*
Ovarian Neoplasms / complications
Ovarian Neoplasms / drug therapy
Remission Induction

Substances

Anti-Allergic Agents
Omalizumab